Pharmacokinetics of cocaine and metabolites following intragastric administration to ten-day-old rat pups

dc.contributor.author	Nyamweya, Nasser N.
dc.contributor.author	Gurley, Bill J.
dc.contributor.author	Breen, Phil
dc.contributor.author	Light, Kim E.
dc.date.accessioned	2013-02-22T10:08:48Z
dc.date.issued	1998
dc.identifier.citation	Pharmaceutical Research, Vol. 15, No.3, 1998	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10744
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/9563082
dc.description.abstract	Fetal cocaine exposure is a major problem resulting from the illicit use of cocaine by pregnant women. Studies examining the prevalence of cocaine use during pregnancy estimate usage ranges from 5-17% (I). Although no definitive syndrome has been defined, prenatal cocaine exposure is associated with decreased birth weight and size, brain injury and congenital anomalies (2).	en
dc.language.iso	en	en
dc.subject	Cocaine	en
dc.subject	Prenatal cocaine exposure	en
dc.subject	Intragastric administration	en
dc.subject	Absorption kinetics	en
dc.subject	Rat pups model	en
dc.title	Pharmacokinetics of cocaine and metabolites following intragastric administration to ten-day-old rat pups	en
dc.type	Article	en